Evidence map›Paper›PMID 30555899›Full record

ArticleACS central science2018

Tumor Retention of Enzyme-Responsive Pt(II) Drug-Loaded Nanoparticles Imaged by Nanoscale Secondary Ion Mass Spectrometry and Fluorescence Microscopy.

Maria T Proetto, Cassandra E Callmann, John Cliff, Craig J Szymanski, Dehong Hu, Stephen B Howell, James E Evans, Galya Orr, Nathan C Gianneschi

Open access · diamondAbstract read
In one paragraph

Article in ACS central science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Achieving a Deeper Understanding of Drug Metabolism and Responses Using Single-Cell Technologies.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Biomedical nanoparticle design: What we can learn from viruses.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Maria T ProettoDepartment of Chemistry & Biochemistry and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, United States.
Cassandra E CallmannDepartment of Chemistry & Biochemistry and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, United States.
John CliffEnvironmental Molecular Sciences Laboratory (EMSL), Pacific Northwest National Laboratory, Richland, Washington 99354, United States.
Craig J SzymanskiEnvironmental Molecular Sciences Laboratory (EMSL), Pacific Northwest National Laboratory, Richland, Washington 99354, United States.
Dehong HuEnvironmental Molecular Sciences Laboratory (EMSL), Pacific Northwest National Laboratory, Richland, Washington 99354, United States.
Stephen B HowellDepartment of Chemistry & Biochemistry and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, United States.
James E EvansEnvironmental Molecular Sciences Laboratory (EMSL), Pacific Northwest National Laboratory, Richland, Washington 99354, United States.
Galya OrrEnvironmental Molecular Sciences Laboratory (EMSL), Pacific Northwest National Laboratory, Richland, Washington 99354, United States.
Nathan C GianneschiDepartment of Chemistry & Biochemistry and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, United States.
Pacific Northwest National Laboratory · USNorthwestern University · USUniversity of California San Diego · US

Funding

U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
NINDS NIH HHS P30 NS047101
6 · The paper itself

Abstract

In nanomedicine, determining the spatial distribution of particles and drugs, together and apart, at high resolution within tissues, remains a major challenge because each must have a different label or detectable feature that can be observed with high sensitivity and resolution. We prepared nanoparticles capable of enzyme-directed assembly of particle therapeutics (EDAPT), containing an analogue of the Pt(II)-containing drug oxaliplatin, an

Identifiers

PMID30555899
PMCPMC6276039
OpenAlexW2897872027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.